Evidence map›Paper›PMID 17584489›Full record

ArticleBMC cancer2007

Small primary adenocarcinoma in adenomyosis with nodal metastasis: a case report.

Giacomo Puppa, Makio Shozu, Tiziana Perin, Kazuhito Nomura, Annunziata Gloghini, Elio Campagnutta, Vincenzo Canzonieri

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC cancer, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review.International journal of environmental research and public health · 2022
    Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Giacomo PuppaDivision of Pathology, Centro di Riferimento Oncologico, Istituto Nazionale Tumori-IRCCS, Aviano PN, Italy. gpuppa@yahoo.com <gpuppa@yahoo.com>
Makio Shozu
Tiziana Perin
Kazuhito Nomura
Annunziata Gloghini
Elio Campagnutta
Vincenzo Canzonieri
Istituti di Ricovero e Cura a Carattere Scientifico · ITCentro di Riferimento Oncologico · ITChiba University · JPKanazawa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalignant transformation of adenomyosis is a very rare event. Only about 30 cases of this occurrence have been documented till now. CASE PRESENTATION: The patient was a 57-year-old woman with a slightly enlarged uterus, who underwent total hysterectomy and unilateral adnexectomy. On gross inspection, the uterine wall displayed a single nodule measuring 5 cm and several small gelatinous lesions. Microscopic examination revealed a common leiomyoma and multiple adenomyotic foci. A few of these glands were transformed into a moderately differentiated adenocarcinoma. The endometrium was completely examined and tumor free. The carcinoma was, therefore, considered to be an endometrioid adenocarcinoma arising from adenomyosis. Four months later, an ultrasound scan revealed enlarged pelvic lymph nodes: a cytological diagnosis of metastatic adenocarcinoma was made. Immunohistochemical studies showed an enhanced positivity of the tumor site together with the neighbouring adenomyotic foci for estrogen receptors, aromatase, p53 and COX-2 expression when compared to the distant adenomyotic glands and the endometrium. We therefore postulate that the neoplastic transformation of adenomyosis implies an early carcinogenic event involving p53 and COX-2; further tumor growth is sustained by an autocrine-paracrine loop, based on a modulation of hormone receptors as well as aromatase and COX-2 local expression.

conclusionAdenocarcinoma in adenomyosis may be affected by local hormonal influence and, despite its small size, may metastasize.

Indexed as

AdenocarcinomaAdenomyomaAromataseCell Transformation, NeoplasticCyclooxygenase 2Endometrial NeoplasmsFemaleHumansHysterectomyImmunohistochemistryLeiomyomaLymphatic MetastasisMiddle AgedNeoplasms, Multiple PrimaryRare DiseasesReceptors, EstrogenAromataseCyclooxygenase 2Receptors, EstrogenTumor Suppressor Protein p53

Identifiers

PMID17584489
PMCPMC1913924
OpenAlexW2043518421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.